Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hazzan

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Annales De Medecine Interne|January 1, 1992
Incidence and clinical profile of microvascular complications in renal allografted patients treated with cyclosporineC Noël, P Saunier, M Hazzan, et al.
Annales Francaises D'Anesthesie Et De Reanimation|August 24, 2002
[Evaluation of verification of brain death and coordination with hospital organ procurement at the University Hospital at Lille]A P Forget, D Roumilhac, M Hazzan, et al.
Gastroenterologie Clinique Et Biologique|November 21, 1998
[Chronic interstitial nephritis and mesalazine: 3 new cases?]M Brouillard, J D Gheerbrant, Y Gheysens, et al.
Presse Medicale (Paris, France : 1983)|December 2, 1992
[Incidence and clinical expressions of microvascular complications in patients receiving kidney graft and treated with cyclosporine]C Noël, P Saunier, M Labalette-Houache, et al.
Archives of Pathology & Laboratory Medicine|April 13, 2001
Bilateral renal oncocytosis with renal failureX Leroy, L Lemaitre, A De La Taille, et al.
Transplantation|April 13, 2000
Immunomodulatory effect of pentoxifylline during human allograft rejection: involvement of tumor necrosis factor-alpha and adhesion moleculesC Noel, M C Copin, M Hazzan, et al.
Transplantation|March 4, 1998
Improvement in the outcome of rejection with pentoxifylline in renal transplantation: a randomized controlled trialC Noel, M Hazzan, M Labalette, et al.
Thrombosis and Haemostasis|December 29, 2000
Pentoxifylline prevents upregulation of monocyte tissue factor in renal transplant recipients undergoing post-graft complicationsS Susen, M Hazzan, M Labalette, et al.
Clinical Transplantation|June 1, 1997
A randomized controlled trial of pentoxifylline for the prevention of delayed graft function in cadaveric kidney graftC Noël, M Hazzan, M C Coppin, et al.
Transplantation|February 27, 1997
Consecutive successful pregnancies in a combined liver and kidney transplant recipient with type 1 primary hyperoxaluriaF R Pruvot, C Noel, N Declerck, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Annales De Medecine Interne|January 1, 1992
Incidence and clinical profile of microvascular complications in renal allografted patients treated with cyclosporineC Noël, P Saunier, M Hazzan, et al.
Annales Francaises D'Anesthesie Et De Reanimation|August 24, 2002
[Evaluation of verification of brain death and coordination with hospital organ procurement at the University Hospital at Lille]A P Forget, D Roumilhac, M Hazzan, et al.
Gastroenterologie Clinique Et Biologique|November 21, 1998
[Chronic interstitial nephritis and mesalazine: 3 new cases?]M Brouillard, J D Gheerbrant, Y Gheysens, et al.
Presse Medicale (Paris, France : 1983)|December 2, 1992
[Incidence and clinical expressions of microvascular complications in patients receiving kidney graft and treated with cyclosporine]C Noël, P Saunier, M Labalette-Houache, et al.
Archives of Pathology & Laboratory Medicine|April 13, 2001
Bilateral renal oncocytosis with renal failureX Leroy, L Lemaitre, A De La Taille, et al.
Transplantation|April 13, 2000
Immunomodulatory effect of pentoxifylline during human allograft rejection: involvement of tumor necrosis factor-alpha and adhesion moleculesC Noel, M C Copin, M Hazzan, et al.
Transplantation|March 4, 1998
Improvement in the outcome of rejection with pentoxifylline in renal transplantation: a randomized controlled trialC Noel, M Hazzan, M Labalette, et al.
Thrombosis and Haemostasis|December 29, 2000
Pentoxifylline prevents upregulation of monocyte tissue factor in renal transplant recipients undergoing post-graft complicationsS Susen, M Hazzan, M Labalette, et al.
Clinical Transplantation|June 1, 1997
A randomized controlled trial of pentoxifylline for the prevention of delayed graft function in cadaveric kidney graftC Noël, M Hazzan, M C Coppin, et al.
Transplantation|February 27, 1997
Consecutive successful pregnancies in a combined liver and kidney transplant recipient with type 1 primary hyperoxaluriaF R Pruvot, C Noel, N Declerck, et al.
Pageof 3